A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

Clinical trial NCT07000136 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07000136
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolaemia

Start date: 2025-06-10
Primary completion: 2027-01-04
Enrollment: 473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.